Back to Journals » Drug Design, Development and Therapy » Volume 19
Network Pharmacology Analysis and Machine-Learning Models Confirmed the Ability of YiShen HuoXue Decoction to Alleviate Renal Fibrosis by Inhibiting Pyroptosis [Retraction]
This retraction applies to:
published online on 24/10/2023Feng M, Luo F, Wu H, et al. Drug Des Devel Ther. 2023;17:3169—3192. https://doi.org/10.2147/DDDT.S420135
We, the Editor and Publisher of Drug Design, Development and Therapy, have retracted the published article.
After publication, image integrity concerns were raised regarding duplicated elements within Figures 4h (LP vs. YSHXD-H) and 5b (NLRP3-YSHXD-L vs. IL-1beta-UUO). When approached for an explanation, the authors did respond to our queries (stating the duplications were due to errors in image assembly) but were unable to provide a satisfactory explanation to address our concerns.
As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors have been informed about this retraction and they have agreed to retract the article.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
This retraction relates to this paper
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.